Protalix BioTherapeutics (PLX) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -3.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.72% |
| Dec 31, 2025 | -30.54% |
| Sep 30, 2025 | -27.76% |
| Jun 30, 2025 | -47.77% |
| Mar 31, 2025 | 73.23% |
| Dec 31, 2024 | -34.06% |
| Sep 30, 2024 | 63.76% |
| Jun 30, 2024 | -26.49% |
| Mar 31, 2024 | 72.97% |
| Dec 31, 2023 | -26.93% |
| Sep 30, 2023 | -67.22% |
| Jun 30, 2023 | 6.08% |
| Mar 31, 2023 | 28.76% |
| Dec 31, 2022 | 454.83% |
| Sep 30, 2022 | 148.01% |
| Jun 30, 2022 | 79.23% |
| Mar 31, 2022 | -252.55% |
| Dec 31, 2021 | 663.84% |
| Sep 30, 2021 | 181.48% |
| Jun 30, 2021 | 302.82% |
| Mar 31, 2021 | -353.95% |
| Dec 31, 2020 | 508.49% |
| Sep 30, 2020 | 310.69% |
| Jun 30, 2020 | 26.90% |
| Mar 31, 2020 | -398.60% |
| Dec 31, 2019 | 28.46% |
| Sep 30, 2019 | -89.06% |
| Jun 30, 2019 | 36.21% |
| Mar 31, 2019 | -8.19% |
| Dec 31, 2018 | -87.18% |
| Sep 30, 2018 | -10.50% |
| Jun 30, 2018 | 21.71% |
| Mar 31, 2018 | -49.08% |
| Mar 31, 2017 | 8.55% |
| Dec 31, 2016 | 3.70% |
| Sep 30, 2016 | 45.99% |
| Jun 30, 2016 | 20.30% |
| Mar 31, 2016 | 24.80% |
| Dec 31, 2015 | 376.40% |
| Sep 30, 2015 | 40.91% |
| Jun 30, 2015 | -1.24% |
| Mar 31, 2015 | 51.20% |
| Mar 31, 2014 | 48.12% |
| Dec 31, 2013 | 36.83% |
| Sep 30, 2013 | 32.85% |